Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Recent tumor genome sequencing confirmed that one tumor often consists of multiple cell subpopulations (clones) which bear different, but related, genetic profiles such as mutation and copy number variation profiles. Thus far, one tumor has been viewed as a whole entity in cancer functional studies. With the advances of genome sequencing and computational analysis, we are able to quantify and computationally dissect clones from tumors, and then conduct clone-based analysis. Emerging technologies such as single-cell genome sequencing and RNA-Seq could profile tumor clones. Thus, we should reconsider how to conduct cancer systems biology studies in the genome sequencing era. We will outline new directions for conducting cancer systems biology by considering that genome sequencing technology can be used for dissecting, quantifying and genetically characterizing clones from tumors. Topics discussed in Part 1 of this review include computationally quantifying of tumor subpopulations; clone-based network modeling, cancer hallmark-based networks and their high-order rewiring principles and the principles of cell survival networks of fast-growing clones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414 · cited 1×
“1): (1) the chromothripsis-driven model [14,15].”
Reactome: a database of reactions, pathways and biological processes
Croft, D., O'Kelly, G., Wu, G., Haw, R., Gillespie, M., Matthews, L., Caudy, M., Garapati, P., Gopinath, G., Jassal, B., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1018 · Cited by 1,751 · cited 1×
“Major signaling pathway databases include Pathway Interaction Database [43] and Reactome [44].”
MethodNon-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
PID: the Pathway Interaction Database
Schaefer, C. F., Anthony, K., Krupa, S., Buchoff, J., Day, M., Hannay, T., & Buetow, K. H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn653 · Cited by 1,603
The Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443 · cited 1×
“Recent tumor genome sequencing studies [10,11] confirmed that many distinct subpopulations of cells, or clones, co-exist in a tumor.”
BackgroundEvolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Properties of cell death models calibrated and compared using Bayesian approaches
Eydgahi, H., Chen, W. W., Muhlich, J. L., Vitkup, D., Tsitsiklis, J. N., & Sorger, P. K. (2013) · Molecular Systems Biology · doi:10.1038/msb.2012.69 · Cited by 84 · cited 1×
“A number of cancer hallmark-based network modeling and network module studies [34–37] have been conducted recently.”
Background
Cited by
Drug–target interaction prediction: databases, web servers and computational models
Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv066 · Cited by 658
Shi, H., Xu, J., Zhang, G., Xu, L., Li, C., Wang, L., Zhao, Z., Jiang, W., Guo, Z., & Li, X. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-101 · Cited by 241
“Signaling networks are a critical cell communication platform for disease development, In particular, strong evidence shows that cancer is a disease with abnormal cell signaling [28].”
BackgroundKATZLDA: KATZ measure for the lncRNA-disease association prediction
Chen, X. (2015) · Scientific Reports · doi:10.1038/srep16840 · Cited by 227
IRWRLDA: improved random walk with restart for lncRNA-disease association prediction
Chen, X., You, Z.-H., Yan, G.-Y., & Gong, D.-W. (2016) · Oncotarget · doi:10.18632/oncotarget.11141 · Cited by 208
miRNA and mRNA expression analysis reveals potential sex-biased miRNA expression
Guo, L., Zhang, Q., Ma, X., Wang, J., & Liang, T. (2017) · Scientific Reports · doi:10.1038/srep39812 · Cited by 116
“For abnormal gene and miRNA expression in tumors, we also checked the cancer hallmark GO terms 33,34 .”
Metadata
- Authors
- Wang, E., Zou, J., Zaman, N., Beitel, L. K., Trifiro, M., & Paliouras, M.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 23
- Issue
- 4
- Pages
- 279-285
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2131773109
- Cited by
- 77
- References
- 8
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks. https://app.cochat.ai/papers/10.1016/j.semcancer.2013.06.002
- The paper
- Wang, E., Zou, J., Zaman, N., Beitel, L. K., Trifiro, M., & Paliouras, M. (2013). Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2013.06.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.